Ranbaxy’s hypertension drug gets approval in Canada
Ranbaxy’s hypertension drug gets approval in Canada
Reuters
Mumbai: Ranbaxy Laboratories has obtained approval to market its generic drug Ran-Lisinopril in Canada, the company said on 22 October.
A company spokesman said Ran-Lisinopril was a branded drug used to treat hypertension.
The drug is the generic form of Zestril tablets made by AstraZeneca Plc, the spokesman said.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!